EN DE

Melisron (MLSR) Fair Value & Analysis

Real Estate · Il · Market cap 19.9B ILA · ISIN IL0003230146

What is Melisron really worth?

M Melisron MLSR · TA
Price434.00 ILA
Fair Value308.91 ILA
Upside−28.8%
Quality53/100

A solid business, but trading 40% above our fair value of 308.91 ILA.

Watch Melisron for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free

Strengths

Highly profitable · 78.8% net margin
Moderate debt · generates free cash flow
Wide moat 71/100

Risks

!Expensive Growth (revenue 5y +15.2 %/yr)
!Mixed vs. peers (8/14)
!Weak on dividend: 26 out of 100
Evidence: High Range 231.68 ILA – 386.14 ILA

Fair value as of: Aug 13, 2026

From 14 valuation models · updated 22 days ago

Share price +10.9% over the past month.

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

What matters now

  • The price sits above even our optimistic bull case (386.14 ILA). The favourable scenario is already priced in.
  • Solid but not exceptional quality (53/100) and above fair value, neither a clear bargain nor a standout compounder.
  • As a real-estate business, asset- and dividend-based methods carry more weight here than a standard DCF.

Price vs Fair Value (5 years)

471.52 ILA 186.60 ILA Fair Value 308.91 ILA Mar 2022 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.

How to read this chart

54‑month range 186.60 ILA – 471.52 ILA · fair‑value band 231.68 ILA – 386.14 ILA · the 434.00 ILA price screens above the 308.91 ILA fair value. Dashed = 300-day average. As of Aug 13, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Melisron (MLSR) currently trades at 434.00 ILA, while our model-based Fair Value estimate is 308.91 ILA, implying the stock looks roughly 40.5% overvalued today. The Quality Score stands at 53/100 (solid quality), in the Real Estate sector. Bull case: the Economic Profit group reads highest at a median of 349.47 ILA per share, and 1 of the 14 models we run sit above the 434.00 ILA price. Bear case: the Growth DCF group reads lowest at 87.11 ILA, and 13 of the 14 models stay below the price. Evidence for this calculation is high.

Over the trailing twelve months, Melisron generated revenue of 2.3B ILA at a net margin of 79.6%. Revenue grew 8.5% year over year. It earns a return on equity of 14.6%. Net debt stands at 14.2B ILA. Fundamentals as of Aug 13, 2026

Our scenario range runs from 231.68 ILA (bear case) to 386.14 ILA (bull case); at 434.00 ILA, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. For context, the median of 10 Real Estate peers we cover trades at −23% fair-value upside, at −29%, MLSR screens richer than that median.

Fair Value models

This estimate rests on fiscal year 2025 figures, and about 8 months have passed since. In that time the company retained roughly 22.82 ILS per share, which is 7.4 % of the fair value. The fair value deliberately does not add this in: the models value reported figures, not a projection.

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted, family-balanced blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small. Every input is real reported data, nothing guessed.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
5Y Revenue Exit 93.87 ILA 319.25 ILA 69
Rev-Margin DCF 87.11 ILA 285.84 ILA 69
5Y EBITDA Exit 21.64 ILA 279.74 ILA 605.94 ILA 67
All 14 models by family
DCF Models
5Y Revenue Exit 93.87 ILA 319.25 ILA 69
5Y EBITDA Exit 21.64 ILA 279.74 ILA 605.94 ILA 67
10Y Revenue Exit 29.60 ILA 254.18 ILA 64
10Y EBITDA Exit 164.69 ILA 490.83 ILA 65
Dividend Discount
Gordon GGM 69.30 ILA 144.08 ILA 228.57 ILA 66
DDM Multi-Stage 69.30 ILA 121.49 ILA 151.22 ILA 66
Multiples
P/S Multiple 231.68 ILA 308.91 ILA 386.14 ILA 58
P/B Multiple 415.46 ILA 553.95 ILA 692.44 ILA 55
EV/EBIT 259.04 ILA 428.19 ILA 597.33 ILA 64
EV/EBITDA 148.79 ILA 281.19 ILA 413.59 ILA 64
EV/Revenue 84.27 ILA 184.08 ILA 50
Asset-Based
NCAV (Graham) 138.49 ILA 185.57 ILA 276.97 ILA 54
Growth DCF
Rev-Margin DCF 87.11 ILA 285.84 ILA 69
Economic Profit
Residual Income 270.33 ILA 349.47 ILA 951.23 ILA 67

Widest divergence: Economic Profit (349.47 ILA) versus Growth DCF (87.11 ILA). Highest evidence: 5Y Revenue Exit (69).

Notify me when MLSR reaches fair value

Put MLSR on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Free, no payment details. Unsubscribe anytime in one click.

Key figures & financial health

P/E ratio 11.0
P/S ratio 8.99 P/E × margin
EPS (TTM) 39.55 ILA price ÷ EPS = P/E 11.0
Dividend yield 1.3% payout 14.3%
Net margin 81.9% FY2025
Return on equity 14.6% TTM
More key figures
Profitability
Return on assets (EBIT) 7.0% avg 5y
Operating margin 66.1% TTM
Growth
Revenue (TTM) 2.3B ILA TTM
Revenue growth (YoY) +8.5% 3y avg +10.7%
EPS growth (YoY) +45.0%
Balance sheet & cash flow
Free cash flow 279M ILA FY2025
Net debt 14.2B ILA FY2025 · ≈ 50.8 yrs of FCF

Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 53/100

Of which business quality 49 · Market factors (momentum, volatility) 58

Profitability 42
Margins and returns on capital today
Quality Growth 44
Are margins and returns improving?
Cashflow 52
Earnings quality: real cash, not paper profit
Fin. Strength 30
Balance sheet, leverage, solvency risk
Investment 65
Disciplined investing over empire-building
Low Volatility 86
Calm price path (market factor)
Momentum 42
Price trend over the last 3–12 months (market factor)
52W Momentum 55
Distance to the 52-week high (market factor)
Net Issuance 79
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.

About the company

Melisron Ltd. operates as a commercial real estate company in Israel. It operates through Income Producing Real Estate and Residential Development and Construction segments.

Full company description

Melisron Ltd. operates as a commercial real estate company in Israel. It operates through Income Producing Real Estate and Residential Development and Construction segments. The company engages in the purchase, construction, operation, rental, management, maintenance, and improvement of commercial centers, including regional, urban and neighbourhood malls and shopping centers; development, construction, owning, maintenance, and management of office complexes and hi-tech parks; residential development and construction, and urban renewal projects. It also owns and manages single-tenant properties and housing complexes. The company's shopping centers serve as shopping, leisure, and entertainment centers. Melisron Ltd. was incorporated in 1987 and is based in Herzliya Pituach, Israel.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Melisron reported revenue of 2.3B ILS in FY2025 versus 1.4B ILS in FY2021, a compound +12.3%/yr. Reported net income was 1.9B ILS in FY2025, compounding +6.0%/yr from FY2021.

Growth Quality 62/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Latest Revenue (FY 2025)
2.3B ILS
Latest YoY
+12.5%
Avg. revenue growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+10.7%
Avg. revenue growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+15.2%
Avg. revenue growth/yr (22Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+13.8%
Value creation/yr (5Y) Earnings growth per share (CAGR 5 years) plus dividend yield: value created per share and year.
+6.9% (5.6 + 1.3)
Revenue +12.3%/yr
FY21 1.4B ILS
FY22 1.7B ILS
FY23 1.8B ILS
FY24 2.0B ILS
FY25 2.3B ILS
Net income +6.0%/yr
FY21 1.5B ILS
FY22 1.4B ILS
FY23 1.0B ILS
FY24 1.5B ILS
FY25 1.9B ILS
Character of growth · EPS growth decomposed (2014-2025) +7.3 % p.a.
Revenue per share +4.1 %

of which total revenue +5.1 % · buybacks/dilution −1.0 %

EBIT margin −1.6 %
Tax rate −0.7 %
Residual (interest, one-offs) +5.5 %

Annual growth per factor. These are factors, not summands: multiplied they give the EPS growth rate, added they do not quite. Start and end points are 3-year averages (details on hover).

MLSR screens 40% overvalued. Compare with CBRE Group →

Share or link this analysis
𝕏 Post WhatsApp LinkedIn Reddit
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Melisron Fair Value". https://www.fairvalue-calculator.com/stock/MLSR

Peer Group

Real Estate Services · 523 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 54 · Below median
Fair Value upside −29% · Below median
Return on equity (TTM) 15% · Top 25%
Return on assets 3% · Above median
Net margin (TTM) 79% · Top 25%
Operating margin (TTM) 63% · Top 25%
Revenue growth 11% · Above median
Dividend yield (TTM) 1.3% · Bottom 25%
Debt / equity 0.99× · Higher than 75% of peers

Valuation Multiples vs Real Estate Services median · lower = cheaper

P/E (TTM) 11.0× · Cheaper than median
P/B 0.50× · Cheaper than median
P/S (TTM) 2.77× · Pricier than median
P/FCF 23.8× · Pricier than 75% of peers
EV/EBITDA 11.8× · Cheaper than median

Strength profile in five axes (Snowflake)

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE0 · sector 30
FUTURE56 · sector 11
PAST59 · sector 17
HEALTH50 · sector 84
DIVIDEND26 · sector 63

VALUE 0: the price sits above our fair-value range.

Insider activity: 40/100

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Real Estate Services stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).

Stock Price Fair Value vs Fair Value
CBRE Group CBRE $148.74 $69.47 −53%
Vonovia SE VNA €19.85 €36.67 +85%
Cellnex Telecom, S.A CLNX €27.47 €25.46 −7%
KE Holdings BEKE $17.42 $6.57 −62%
Jones Lang LaSalle Incorporated JLL $378.01 $290.25 −23%
Swire Properties Limited 1972 HK$24.84 HK$5.12 −79%
CoStar Group CSGP $32.22 $4.64 −86%
China Resources Mixc Lifestyle Services Limited 1209 HK$39.84 HK$34.95 −12%
CapitaLand Investment Limited 9CI 2.66 SGD 0.4900 SGD −82%
Plaza S.A MALLPLAZA 4,040 CLP 4,571 CLP +13%

Compare Melisron with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Real Estate stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screener Filter by region, size and sector Compare tool Two stocks side by side Extrinsic Value Calculator (Options) Splits an option premium into intrinsic and extrinsic (time) value. Peter Lynch Fair Value Formula & Calculator Apply Peter Lynch's fair value formula in seconds: fair P/E ≈ earnings growth (+ dividend) - free, with formula and example.

Frequently asked questions

Is Melisron (MLSR) overvalued or undervalued?
As of Aug 13, 2026, our model estimates a fair value of 308.91 ILA versus a price of 434.00 ILA, about −29% upside (overvalued).
What is the fair value of MLSR?
Our model-based fair value for Melisron is 308.91 ILA (as of Aug 13, 2026), built from audited fundamentals. The current price: 434.00 ILA.
What is the quality score of MLSR?
Melisron has a Quality Score of 53/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Melisron (MLSR)?
Melisron reported trailing-twelve-month revenue of about 2.3B ILS (latest available figure, as of Aug 13, 2026).
What is the net profit margin of MLSR?
The net profit margin of Melisron is about 79.6%, meaning it keeps roughly 79.6% of revenue as net income. Based on the latest reported figures.
Does Melisron pay a dividend?
Melisron currently shows a dividend yield of about 1.31% relative to its recent price (as of Aug 13, 2026).
Free · no account needed

Watch Melisron in the live analysis

One click puts Melisron on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.